Relief Therapeutics Holding AG (RLFTF)

[tendies]

Aviptadil is only one of a half dozen treatments mentioned by doctors on their short list of treatments that work. (I have confirmation from few sources that work in Houston Methodist, or close colleagues who are medical personnel that have inside insight confirming this. With Remdesivir supplies running out and 3 million doses on standby of Aviptadil, expect some fast movement here. Thursday was the committee review. So news is imminent this week.

IF, this is a big IF. If the FDA allows the patients from the compassionate care cohort to be counted in the placebo controlled cohort to meet the 102 patient minimum target for trial completion, we could in theory have FDA approval end of next week.